Pharmacoeconomic Analysis of Treatment of Child Bronchopneumonia With Four Varieties of Cephalospo-rins
- VernacularTitle:4种头孢类抗生素治疗儿童支气管肺炎的成本-效果分析
- Author:
Xiaoyun QIAO
;
Daiyan KONG
;
Yaping SHAO
- Publication Type:Journal Article
- Keywords:
child bronchopneumonia;
pharmacoeconomics;
cost-effectiveness
- From:
China Pharmacy
1991;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To carry out the cost-effectiveness analysis of treating child bronchopneumonia with cefazolin,cefatrizine,cefataxime and cefuroxime METHODS:Using retrospective study and cost-effectiveness analysis,the costs of tre_atment of children with bronchopneumonia were calculated and pharmacoeconomically evaluated RESULTS:The costs of cefazolin,cefatrizine,cefuroxime and cefataxime in treatment of child bronchopneumonia were RMB 512 84,725 42,796 28 and 734 16 yuan and the cost-effectiveness ratios were 93 68,475 83,517 30 and 412 28 respectively CONCLUSION:In comparison with cefatrizine,cefuroxime and cefataxime,cefazolin is the most inexpensive one However,in evaluating the therapeutic cost of a drug, we should consider its therapeutic efficacy and course
